Koji Enomoto

2.1k citations
48 papers · 1.7k indexed · 1 hit paper · h-index 16
Topics
Gastric Cancer Management and Outcomes (12 papers)Cancer Treatment and Pharmacology (9 papers)Breast Cancer Treatment Studies (8 papers)
Partner nations
JapanUnited StatesIndia

In The Last Decade

Koji Enomoto

44 papers receiving 1.6k citations

Hit Papers

Clinical Significance and Therapeutic Potential of the Pr...20072026201320192007200400600

Peers

Koji Enomoto
Comparison fields: 5 of 89
  • Oncology 1.0k
  • Surgery 537
  • Pulmonary and Respiratory Medicine 451
  • Immunology 442
  • Molecular Biology 213
Replace M Miyamoto with:
M Miyamoto Japan
Hiroshi Ariyama Japan
Takahiro Akahori Japan
Shinichi Tsutsui Japan
Dalibor Antolovic Germany
Hiromichi Kawaida Japan
Hideya Takeuchi Japan
Shinsuke Kazama Japan
Paolo Castellano Italy
Hisahiro Hosogi Japan
Koji Enomoto relative to M Miyamoto Japan M Miyamoto's profile →
Citations per field
00.5×1.5×2.1×
M Miyamoto · 1×
Citations per year

Countries citing papers authored by Koji Enomoto

Since Specialization
Citations

This map shows the geographic impact of Koji Enomoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Enomoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Enomoto more than expected).

Fields of papers citing papers by Koji Enomoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Enomoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Enomoto. The network helps show where Koji Enomoto may publish in the future.

Co-authorship network of co-authors of Koji Enomoto

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Enomoto. A scholar is included among the top collaborators of Koji Enomoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Enomoto. Koji Enomoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 286
3 5
4 30
5 28
6
Prognostic significance of splenic hilar nodal involvement in proximal third gastric carcinoma.
5
7 7
8 2
9 44
10 51
11
Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancerbreakdown →
729
12 17
13 21
14 6
15 4
16 5
17 6
18 3
19
[Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
5
20 51

About Koji Enomoto

Koji Enomoto is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 48 papers that have together received 1.7k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (12 papers), Cancer Treatment and Pharmacology (9 papers) and Breast Cancer Treatment Studies (8 papers). The work is most often cited by research in Oncology (1.0k citations), Immunology (442 citations) and Pulmonary and Respiratory Medicine (451 citations). Koji Enomoto has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Yoshiyuki Nakajima, Shinji Nakamura, Masayuki Sho, Takeo Nomi, Hiromichi Kanehiro, Takahiro Akahori, Miyuki Azuma, Atsushi Kubo, Kaoru Hamada and Hideo Yagita∥. Their work appears in journals such as Cancer, Clinical Cancer Research and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026